Elevated FGF21 levels in conditions like metabolic syndrome, obesity, insulin resistance, diabetes, and hypertension suggest a response to poor metabolic status (Tan et al., 2023; Gao et al., 2019). This evidence concerns the gene FGF21 and obesity disorder.